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he host hormone melatonin increases cytoplasmic
Ca
 
2
 
 
 
 concentration and synchronizes 
 
Plasmodium
 
cell cycle (Hotta, C.T., M.L. Gazarini, F.H. Beraldo,
F.P. Varotti, C. Lopes, R.P. Markus, T. Pozzan, and C.R.
Garcia. 2000. 
 
Nat. Cell Biol.
 
 2:466–468). Here we
show that in 
 
Plasmodium falciparum
 
 melatonin induces an
increase in cyclic AMP (cAMP) levels and cAMP-dependent
protein kinase (PKA) activity (40 and 50%, respectively).
When red blood cells infected with 
 
P. falciparum
 
are treated with cAMP analogue adenosine 3
 
 
 
,5
 
 
 
-cyclic
monophosphate N6-benzoyl/PKA activator (6-Bz-cAMP)
there is an alteration of the parasite cell cycle. This effect
appears to depend on activation of PKA (abolished by
T
 
the PKA inhibitors adenosine 3
 
 
 
,5
 
 
 
-cyclic monophos-
phorothioate/8 Bromo Rp isomer, PKI [cell permeable
peptide], and H89). An unexpected cross talk was
found to exist between the cAMP and the Ca
 
2
 
 
 
-dependent
signaling pathways. The increases in cAMP by melatonin
are inhibited by blocker of phospholipase C U73122,
and addition of 6-Bz-cAMP increases cytosolic Ca
 
2
 
 
 
 con-
centration, through PKA activation.
These ﬁndings suggest that in 
 
Plasmodium
 
 a highly
complex interplay exists between the Ca
 
2
 
 
 
 and cAMP
signaling pathways, but also that the control of the para-
site cell cycle by melatonin requires the activation of both
second messenger controlled pathways.
 
Introduction
 
Plasmodium
 
, the etiological agent of malaria and a major cause
of death in the third world, is a unicellular parasite that in hu-
mans spends most of its life span within intact hepatocytes and
red blood cells (RBCs) (Aravind et al., 2003; Bannister and
Mitchell, 2003). Within the latter cells, in particular, 
 
Plasmo-
dium
 
 multiplies and maturates in the forms ready to invade
other erythrocytes. The increase in drug resistance of malaria
parasites (Hall et al., 2003; Le Bras and Durand, 2003; Snow et
al., 2005) is a dramatic and worrisome phenomenon that calls
for an urgent elucidation of the mechanisms by which the para-
site controls its developmental events (Bozdech et al., 2003).
Although the 
 
Plasmodium
 
 genome sequencing is now com-
plete, 60% of the proteins do not have sufficient similarity to
any proteins in other organisms (Gardner et al., 2002) to allow
comparative studies to be easily performed.
We have reported that Plasmodia have subverted the host
endocrine system using the hormone melatonin to modulate its
cell cycle (Hotta et al., 2000). The effect of melatonin appears
to depend, at least in part, on the production of InsP
 
3
 
, a well-
characterized second messenger for Ca
 
2
 
 
 
 mobilization from in-
tracellular organelles (Pozzan et al., 1994; Berridge et al.
 
,
 
2003). We have also recently shown that the 
 
Plasmodium,
 
 once
it has infected the RBCs, creates around itself a microenviron-
ment, the parasitophorous vacuole, rich in Ca
 
2
 
 
 
, that is neces-
sary to fully exploit the Ca
 
2
 
 
 
 signaling pathway (Camacho,
2003; Gazarini et al.
 
,
 
 2003). These and other data from differ-
ent laboratories support the notion that Plasmodia, as most
other eukaryotic cells, use the Ca
 
2
 
 
 
 signaling pathway for the
control of a number of vital functions (Passos and Garcia,
1998; Garcia, 1999; Garcia et al., 1996, 1998; Hotta et al.,
2000; Marchesini et al., 2000; Alleva and Kirk, 2001; Varotti et
al., 2003), primarily their progression throughout the cell cycle.
Of interest, triptophane-related molecules could also induce
Ca
 
2
 
 
 
 release in 
 
Plasmodium
 
 and modulate its cell cycle (Be-
raldo and Garcia, 2005). The role of Ca
 
2
 
 
 
 in 
 
Plasmodium
 
 cycle
remains to be investigated although its transient rise was shown
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by internally quenched fluorescent peptides to activate parasite
thiol proteases (Farias et al., 2005).
Relatively more scarce is the understanding of the impor-
tance of the other ubiquitous second messenger, cAMP, though
evidence suggests that cAMP is also implicated in 
 
Plasmodium
 
maturation and/or differentiation. cAMP has been in fact re-
ported to promote in vitro gametocytogenesis (Kaushal et al.,
1980; Trager and Gill, 1989; Dyer and Day, 2000) and to im-
pair maturation of merozoite within RBCs (Inselburg, 1983).
Furthermore an increase of both adenylyl cyclase and cAMP-
dependent protein kinase (PKA) activities accompanies 
 
Plas-
modium falciparum
 
 differentiation (Read and Mikkelsen,
1991a,b) whereas inhibition of PKA activity blocks parasite
multiplication. The importance of cAMP in 
 
Plasmodium
 
 differ-
entiation to gametocytes, the mosquito-infective form, has
been known for a long time (Trager and Gill, 1989).
The molecular machinery controlling cAMP production,
degradation, and sensitivity of Plasmodia appear to be similar
to that of higher eukaryotes. Thus a gene encoding the catalytic
subunit of PKA (PKA-C) from the rodent and human malaria
parasites has been cloned (Li and Cox, 2000; Ward et al.,
2004); similarly, genes encoding a subunit resembling the
mammalian PKA regulatory subunits, PKA-R, the cAMP-
degrading enzyme phosphodiesterases and the adenylyl cyclase
are all known to be present in the 
 
Plasmodium
 
 genome (Gard-
ner et al., 2002). Last, but not least, PKA-C transcript levels are
higher in intraerythrocytic stages, decreasing in gametocytes
and gametes (Ward et al., 2004).
Given that in high eukaryotes there are complex synergis-
tic and antagonistic effects between Ca
 
2
 
 
 
 and cAMP (Bruce et
al., 2003), we decided to investigate whether this could also be
true in Plasmodia. In particular we addressed the question of
whether melatonin affects not only the Ca
 
2
 
 
 
 signaling pathway,
but also that controlled by cAMP. Our results demonstrate that
the host hormone not only regulates both second messengers,
but also that they influence each other and both contribute to
the control of the parasite cycle.
 
Results
 
Melatonin increase cAMP levels in 
 
Plasmodium
 
: PLC inhibition impairs 
melatonin action
 
To investigate the effects of melatonin on cAMP levels in Plas-
modia, isolated 
 
P. falciparum
 
 parasites, at the throphozoite
stage, free of host cells to avoid interference from cAMP of
RBCs, were treated with 100 nM melatonin. Fig. 1 shows that
addition of the hormone leads to an increase of cAMP from 82.2 
 
 
 
5.0 fmoles/
 
 
 
g protein to 125.2 
 
 
 
 3.0 fmoles/
 
 
 
g protein in the
presence of 3-isobutyl-1-methylxanthine (IBMX), a phosphodi-
esterase inhibitor (100 
 
 
 
M), although in the absence of IBMX
the cAMP levels rose from 21.8 
 
 
 
 0.1 fmoles/
 
 
 
g protein to 42.0 
 
 
 
5.0 fmoles/
 
 
 
g protein. Unexpectedly the increases in cAMP
caused by melatonin are inhibited by blockers of phospholipase
C such as U73122 (10 
 
 
 
M; Fig. 1), suggesting an important role
of Ca
 
2
 
 
 
 in the control of cAMP production/degradation. To in-
vestigate if the rise of Ca
 
2
 
 
 
 per se could lead to a cAMP increase,
we added the Ca
 
2
 
 
 
 ionophore ionomycin (10 
 
 
 
M) to the para-
sites. Fig. 1 shows that the Ca
 
2
 
 
 
 ionophore causes an increase of
cAMP similar to that observed with melatonin. Moreover the
melatonin effect was blocked by the intracellular Ca
 
2
 
 
 
 chelator
(25 
 
 
 
M BAPTA) and by the calmodulin inhibitor (10 
 
 
 
M cal-
midazolium). No increase of cAMP by melatonin was observed by
treating the parasites with the kinase inhibitor (1 
 
 
 
M stauro-
sporin) or with the inactive analogue of the PLC inhibitor
U73343 (10 
 
 
 
M; Fig. 1). As previously reported (Read and
Mikkelsen, 1990; Muhia et al., 2003) forskolin has no effect on
 
Plasmodium
 
 cAMP levels (unpublished data).
 
Cell cycle development is modulated by 
cAMP signaling pathway
 
As the above data indicates that melatonin can increase
cAMP levels, we investigated whether PKA inhibitors of
cAMP action such as adenosine 3
 
 
 
,5
 
 
 
-cyclic monophospho-
rothioate/8 Bromo Rp isomer (8-BrcAMP-RP isomer), PKI,
and H89 or PKA activators such as adenosine 3
 
 
 
,5
 
 
 
-cyclic
monophosphate N6-benzoyl/PKA activator (6-Bz-cAMP),
that can cross cell membranes, had any effect on parasite cell
cycle. Experiments were performed by incubating the drugs
(for 24 h) with asynchronous 
 
P. falciparum
 
 cultures followed
by fixation of the cells and counting of the parasites and of
their differentiation stages. Addition of 100 nM melatonin, as
reported previously (Hotta et al., 2000), induced an increase
of the schizont stage of 158% with a concomitant decrease of
the ring and trophozoite stages of 50 and 13%, respectively
(Fig. 2 A). When the 
 
P. falciparum
 
 cultures were treated with
the PKA activator, 6-Bz-cAMP (20 
 
 
 
M) we observed an in-
crease of the schizont stage similar to that observed with mel-
atonin (Fig. 2 A). Addition of IBMX alone also induced an
increase of the schizont stage of 76% (unpublished data). The
Figure 1. Measurement of cAMP levels in P. falciparum parasites. Experi-
ments were performed by using isolated parasites at trophozoite stage
treated with 100 nM melatonin in the presence or absence of 100  M
IBMX. Cells were incubated with: 10  M U73122, 10  M ionomycin, 25
 M BAPTA, 10  M calmidazolium, 1  M staurosporin, and 10  M
U73343. After treatment, samples were analyzed with cAMP enzyme immu-
noassay kit (Amersham Biosciences). There was a significant variation with
melatonin addition (one-way analysis of variance vs. Newman-Keuls test,
P   0.05). Results represent duplicated data from three different experiments. 
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effects of melatonin, in the increasing of schizont stage, were
inhibited by the PKA inhibitors PKI (20 
 
 
 
M; increase of 14%
in relative to control), 8-BrcAMP-RP isomer (increase of
49% relative to control; Fig. 2 B), and H89 (inhibition of 11%
relative to control; unpublished data).
 
PKA activity in 
 
Plasmodium
 
 parasites
 
To further investigate the involvement of PKA as a transducer
of melatonin action on 
 
Plasmodium
 
 cell cycle we measured
PKA activity upon hormone treatment in cell extracts of 
 
P.
falciparum
 
 (at the throphozoite stage). The percentage of PKA
activity, as stimulated by each treatment, is compared with the
maximal PKA activity, as obtained upon addition to the assay
of 1 
 
 
 
M cAMP. Fig. 3 shows that activity of PKA in nonstim-
ulated cultures of 
 
P. falciparum
 
 is 7.2 
 
 
 
 1.2% of maximal ac-
tivity. Treatment with 100 nM melatonin induced an increase
a PKA activity to 39.3 
 
 
 
 7.8% of maximum. Addition of 100
 
 
 
M IBMX alone increased PKA activity to 26.5 
 
 
 
 7.8%, con-
sistent with the results obtained in intact cells demonstrating
that this phosphodiesterase inhibitor alone increases parasite
cAMP levels. Finally the treatment with 100 nM melatonin
plus 100 
 
 
 
M IBMX increased PKA activity to 57.3 
 
 
 
 7.4% of
maximum. Addition to the assay of PKI, a specific PKA inhib-
itor, completely abolished cAMP induced phosphorylation of
kemptide (unpublished data). A similar effect was observed
when cells were treated with H89 before the measurements of
PKA in the cell extracts (unpublished data).
 
Ca
 
2
 
 
 
 and cAMP interplay
 
Fig. 4 shows that addition of 100 nM melatonin to isolated 
 
P. fal-
ciparum parasites at trophozoite stages, loaded with calcium in-
dicator Fluo-4, induced a rapid increase of cytoplasmic Ca
2 
concentration. We observed the same rise when melatonin was
added in a medium containing 2 mM CaCl2 (Fig. 4 A), in a Ca
2 
free medium (  100  M EGTA; Fig. 4 B) or when parasites
were incubated with the PKA inhibitor PKI (Fig. 4 C). These re-
sults indicated that the increase of Ca
2  induced by melatonin is
independent of extracellular Ca
2  or PKA activation.
Addition of the cAMP analogue 6-Bz-cAMP to the para-
sites, in a medium with 2mM CaCl2, induced a cytoplasmic
[Ca
2 ] increase similar to that observed with melatonin (Fig. 4
D). However, in Ca
2 -free medium the increase of cytoplasmic
[Ca
2 ] promoted by 6-Bz-cAMP was transient, unlike observed
in Ca
2  medium (Fig. 4 E). To investigate if cAMP itself or
PKA activation were responsible for the increases of citosolic
[Ca
2 ] we added the cAMP analogue, 6-Bz-cAMP in P. falcip-
arum loaded with Fluo-4 in the presence of the PKA inhibitor
PKI. Under these conditions, 6-Bz-cAMP did not promote an
increase of cytoplasmic Ca
2 , thus indicating that the Ca
2  in-
crease caused by cAMP (Fig. 4 F) depends on the activation of
PKA. Finally 6-Bz-cAMP was added to cells pretreated with
the PLC inhibitor U73122 (Fig. 4 G). Unlike the results ob-
tained with melatonin (where the Ca
2 increase is completely
blocked by the drug) in the case of 6-Bz-cAMP the increase in
cytoplasmic Ca
2  was insensitive to the PLC inhibitor, suggest-
ing that either PKA is able to promote an increase of cytosolic
Ca
2  independently of PLC or that the kinase activates a PLC
isoform insensitive to U73122.
To better understand the origin, mechanism and possible
interactions of the cytoplasmic Ca
2  increases caused by melato-
nin and PKA activators, in the experiments presented in Fig. 5
Figure 2. Effect of cAMP signaling drugs on P. falciparum cell cycle de-
velopment in vitro. Incubation for 24 h at 37 C in 24-well plates with re-
agents: 100 nM MLT, 20  M PKI, 20  M 8-BrcAMP-RP isomer, and 20
 M 6-Bz-cAMP. Values are the percentage of parasitemia variation to
control: (A) R, ring; T, trophozoite; and S, Schizont parasites stages; and
(B) total parasitemia. The parasitemia (percentage of red cells infected)
was determined by count of infected cells (1,000) from three different ex-
periments. In these experiments the initial parasitemia was around 5%
and the maximal parasitemia was around 15%. Data were compared by
one-way analysis of variance and a Newman-Keuls test. *, Statistical sig-
nificance with respect to control values P   0.01.
Figure 3. PKA activity levels in P. falciparum parasites. Isolated parasites
at trophozoite stage treated with 100 nM MLT, 100  M IBMX, or MLT
and IBMX. Data was calculated from duplicated data from three different
experiments assays, as a percentage of total PKA activity obtained with
an additional 1  M cAMP.JCB • VOLUME 170 • NUMBER 4 • 2005 554
the effects on cytoplasmic Ca
2  of the combination of these
treatments are presented. Addition of 6-Bz-cAMP after melato-
nin (Fig. 5 A) was without effect and, similarly, the addition of
melatonin after 6-Bz-cAMP (Fig. 5 B) did not promote a further
increase of intracellular Ca
2 , suggesting that the two pathways
converge on the same mechanism. We finally tested the effect of
the inhibitor of the sarcoendoplasmic reticulum Ca
2  ATPase
thapsigargin, THG. This drug, when added to cells (either in
Figure 4. Ca
2  fluorescence measurement in P. falciparum parasites analyzed by confocal microscopy. Parasites at trophozoite stage were loaded with Fluo-4
AM. (see Materials and methods) and its fluorescence ratio (F1/F0) intensity was plotted as a function of time. (A–C) Addition of 100 nM melatonin in buffer
with 2 mM Ca
2  promotes an increase of 1.4   0.4 (n   18) and similar results was observed with melatonin 100 nM in the presence of PKI in a Ca
2  medium
or in a Ca
2 -free medium, respectively. (D) 20  M 6-Bz-cAMP resulted in 1.5   0.1 (n   6). (E) 20  M 6-Bz-cAMP was added in Ca
2 -free medium (EGTA con-
taining) and causes a transient fluorescence increase of 1.36   0.2 (n   4). (F) 20  M 6-Bz-cAMP did not induce an increase of Ca
2  when added in the pres-
ence of PKA inhibitor PKI. (G) 20  M 6-Bz-cAMP induced an increase of Ca
2  of 1.41   0.3 (n   3) in the presence of PLC inhibitor U73122 (10  M).
Figure 5. Ca
2  fluorescence measurement in P. falciparum parasites analyzed by confocal microscopy. Parasites at trophozoite stage were loaded with
Fluo-4 AM (see Materials and methods) and its fluorescence ratio (F1/F0) intensity was plotted as a function of time. (A) Addition of 100 nM melatonin in
buffer with 2 mM Ca
2 : the mean increase of fluorescence ratio was 1.32   0.2 (n   11) no effect was observed with a further addition of 20  M 6-Bz-
cAMP. (B) Addition of 20  M 6-Bz-cAMP caused an average an increase in fluorescence ratio of 1.40   0.3 (n   5) and no effect was observed with a
further addition of melatonin. (C) Same conditions as above. When indicated 10  M THG was added. (D and E) Where indicated THG and 6-Bz-cAMP
were added. In D the medium contained 2 mM CaCl2 whereas in E no Ca
2  was added and 100  M EGTA was included instead.CALCIUM AND CAMP INTERPLAY IN MELATONIN REGULATION ON MALARIA PARASITES • BERALDO ET AL. 555
Ca
2 -containing or Ca
2 -free medium) causes a transient in-
crease in cytoplasmic [Ca
2 ], due to Ca
2  release from intracel-
lular stores (Hotta et al., 2000). When the parasites, incubated in
Ca
2 -free medium, were treated first with THG and then with
6-Bz-cAMP no increase in [Ca
2 ] was observed (Fig. 5 E). Similar
results, i.e., no rise in response to the second stimulus, were ob-
tained when the order of drug addition was reversed, suggesting
that 6-Bz-cAMP acts on a Ca
2  store endowed with a THG-sen-
sitive Ca
2  ATPase (unpublished data). However, in Ca
2 -con-
taining medium, although addition of THG after 6-Bz-cAMP re-
sulted in no further increase of cytosolic Ca
2  (Fig. 5 C), THG
pretreatment, though inducing the usual transient increase of cy-
tosolic Ca
2 , did not prevent the rise in [Ca
2 ] caused by 6-Bz-
cAMP (Fig. 5 D). The latter result suggests that, in addition to
mobilizing Ca
2  from intracellular stores 6-Bz-cAMP promotes
an influx of Ca
2  from the extracellular medium. Taken together
these data demonstrate that: (a) an increase in cAMP causes the
mobilization of Ca
2  from intracellular stores endowed with a
THG-sensitive Ca
2  ATPase; (b) the Ca
2  stores mobilized by
melatonin, through PLC produced InsP3, are the same as those
mobilized by a cAMP increase; and (c) the cAMP rise also acti-
vates an influx of Ca
2  from the extracellular medium.
Discussion
Intraerythrocytic development of Plasmodium parasites de-
pends on a series of complex signaling pathways in which sec-
ond messengers such as Ca
2  and cAMP appear to play a key,
yet largely mysterious, role. In the present work we have stud-
ied in details the involvement of cAMP and of its classical tar-
get enzyme PKA on the development within RBCs of P. falcip-
arum and on the Ca
2  signaling mechanisms, in particular in
relation to the modulatory effects on the cell cycle elicited by
the host-derived hormone melatonin.
Our data show that: (a) melatonin increases cAMP levels
and activates PKA; (b) inhibition of PKA strongly reduces the
effects of melatonin on P. falciparum cell cycle; (c) a cAMP in-
crease, as induced either by inhibiting the cAMP phosphodi-
esterases with IBMX or by adding the membrane permeable
cAMP analogue N6cAMP mimics the effects of melatonin on
cell cycle. Taken together these data make a strong case in favor
of a key role played by cAMP and PKA as key modulators of the
cell cycle in this malaria parasite. As to the mechanisms through
which melatonin increases cAMP levels in P. falciparum the ob-
servations that (a) the inhibition of PLC by U73122 prevents the
cAMP increase induced by melatonin and (b) a rise in cAMP in-
duced by artificially increasing the cytosolic Ca
2  concentration
with the Ca
2  ionophore ionomycin, suggest that the increase in
cytosolic Ca
2  concentration caused by melatonin, rather than a
direct coupling of the melatonin receptors to adenylyl cyclase is
involved in the augmentation of the parasite cAMP levels.
Whether this rise is due to activation by Ca
2  of an adenylyl cy-
clase (Cooper et al., 1995), or whether it is due to inhibition of a
phosphodiesterase remains to be established. However, the ob-
servation that the melatonin-induced cAMP increase is observed
also in the presence of the rather unspecific phosphodiesterase
inhibitor IBMX suggests that the first possibility is more likely.
The interactions between the cAMP and the Ca
2  signal-
ing pathways are not however limited to the Ca
2 -dependent ac-
tivation of cAMP production; in fact we also observed that the
PKA activator 6-Bz-cAMP is capable of inducing a cytosolic
Ca
2  increase in the intact parasites, in part by mobilizing Ca
2 
from intracellular stores and in part by stimulating Ca
2  influx
from the medium. It is worth noting that the stores that are mo-
Figure 6. Schematic model of signaling events in Plasmodium with data provided from literature and our results. AC, adenylyl cyclase; PLC, phospholi-
pase C; PDE, phosphodiesterase; PKA, protein kinase A; ER, endoplasmic reticulum; R, hypothetical melatonin receptor.JCB • VOLUME 170 • NUMBER 4 • 2005 556
bilized by the rise in cAMP and those sensitive to InsP3 pro-
duced by melatonin receptor stimulation appear to be the same,
in as much as: (a) once Ca
2  has been released by cAMP, mela-
tonin had no further effect (and vice versa); and (b) Ca
2  mobili-
zation by cAMP or melatonin both occur from an organelle en-
dowed with a THG-sensitive Ca
2  ATPase (i.e., presumably the
endoplasmic reticulum). However, the mechanisms through
which cAMP or melatonin cause the release of Ca
2  from the
endoplasmic reticulum are clearly different. In particular, Ca
2 
mobilization by melatonin is insensitive to PKA inhibition (and
thus it is independent of the cAMP rise), but it is sensitive to the
PLC inhibitor U73343 (and thus presumably depends on InsP3
production); on the contrary cAMP-induced Ca
2  mobilization
is sensitive to PKA inhibition, but it is insensitive to U73343,
indicating that either the cAMP rise induce the activation of an-
other PLC isoform or that it causes the release of Ca
2  through
an InsP3-insensitive pathway. Whether PKA activates a yet un-
known endoplasmic reticulum channel different from the InsP3
receptor or whether it activates the InsP3 receptors at basal level
of InsP3 remains to be investigated.
In the light of the present results we thus propose the fol-
lowing model: (a) melatonin promotes a cytosolic [Ca
2 ] rise by
increasing InsP3 production; (b) the rise in [Ca
2 ] stimulates
cAMP production, as parasites treated with the phospholipase C
blocker, U73122 do not show any increase in cAMP upon mela-
tonin treatment; (c) changes in intracellular cAMP concentration
induce further Ca
2  release (by an as yet unknown mechanism).
Last, but not least, the cAMP increase induces in P. falcip-
arum the activation of a Ca
2  influx pathway whose nature and
mechanism of activation is yet to be determined.
In conclusion, the present and previous results suggest
that the modulation of Plasmodia cell cycle by the host hor-
mone melatonin is mediated by two second messengers acting
in concert: on the one hand, melatonin is directly coupled to a
classical Ca
2  signaling pathway, via phospholipase C–depen-
dent InsP3 production and Ca
2  mobilization from stores; on
the other, the Ca
2  rise initiates an amplification loop via
cAMP and PKA that further modulates the Ca
2  signal.
In mammalian cells recent work has demonstrated that
not all the effects of cAMP are mediated by PKA, as several
other cAMP binding proteins exist and appear to mediate,
PKA-independent, cAMP-activated cellular processes (Stork
and Schmitt, 2002; Kopperud et al., 2003). However, this ap-
pears to not be the case for the melatonin effects on cell cycle
of P. falciparum as all the hormone effects on the development
of the intracellular parasites described here are strongly inhib-
ited by PKA inhibitors such as H89, PKI, and 8-BrcAMP-RP
isomer. Whether Ca
2  has other effects on the parasite develop-
ment, independent of its capacity to modulate PKA down-
stream signaling remains to be established. Fig. 6 summarizes
melatonin signaling pathways in Plasmodium.
Materials and methods
Parasites
P. falciparum, Palo Alto strain, were cultured in flasks with RPMI 1640 me-
dium as previously described (Trager and Jensen, 1976). Parasitemias
were determined from Giemsa-stained smears.
Plasmodium cell cycle
These experiments were performed with Plasmodium-infected erythrocytes.
P. falciparum–infected cells incubation was performed for 24 h at 37 C on
plates in a closed chamber with controlled atmosphere in stationary condi-
tion. The proportion of different parasite forms as well as parasitemia was
determined by analyzing 1,000 RBCs on Giemsa-stained slides after the
following incubations: 100 nM melatonin; 20  M PKA inhibitors/PKI (cell
permeable), 20  M H89 and 20  M 8-BrcAMP-RP isomer; 100  M IBMX;
20  M PKA activator/6-Bz-cAMP. Control with solvent blank (DMSO, etha-
nol) used in the dilutions of the reagents were assayed.
cAMP enzyme immunoassay
P. falciparum–infected cells at trophozoite stage, synchronized with sorbi-
tol (Lambros and Vanderberg, 1979), were submitted to the melatonin
treatment 18 h after synchronization. P. falciparum parasites, isolated at
the trophozoite stage, as described previously (Hotta et al., 2000), were
washed twice with PBS, resuspended at a concentration of 5   10
6 cells
ml
 1 in the same buffer and incubated for 15 min with 100 nM melatonin,
20  M phospholipase-C inhibitor (U73122), 1  M staurosporin (kinase
inhibitor), calmidazolium (calmodulin inhibitor), 10  M ionomycin, or 25
 M BAPTA in the presence or absence of 100  M IBMX to prevent cAMP
degradation. After treatment, samples were analyzed with cAMP enzyme
immunoassay kit (Amersham Biosciences) following protocol No. 4. Paral-
lel experiments with no treatment were also carried on as control. Controls
with solvents did not show an increase of cAMP.
PKA activity
P. falciparum malaria parasites were isolated from RBCs as described
above and resuspended in PBS. Parasites (5   10
6 cells in 200  l) were
incubated by 15 min in the presence of 100 nM melatonin and/or 100
 M IBMX. After incubation the parasites resuspended in 500  l of extrac-
tion buffer (25 mM Tris/HCl, pH 7.4, 0.5 mM EDTA, 0.5 mM EGTA, and
10 mM  -mercaptoethanol) supplemented with protease inhibitors (leu-
peptin, pepstatin A, antipain, and chymostatin at 20  g ml
 1 and benza-
midine at 0.5 mM). Parasites kept on ice bath were then broken by soni-
cation (15W/15 s) and the lysates were centrifuged (14,000 g, 4 C for 5
min). Protein concentration in the supernants was determined by BCA Pro-
tein Assay Kit (Pierce Chemical Co.) using bovine serum albumin as stan-
dard. PKA activity was assayed by 
32P phophorylation of kemptide
(Sigma-Aldrich) as previously described (Goueli et al., 1995). The assay
was performed in a total volume of 100  l containing 50  l of parasites
lysates supernatant (120–140  g of protein) and 50  l of PKA reaction
buffer (40 mM Tris/HCl, pH 7.4, 50  M kemptide, 25  M [ 
32P]ATP
(100 mCi/mmol
 1), 25  M ATP, 10 mM MgCl2, 0.2 mg/ml
 1 BSA). After
5 min at 30 C, the reaction was stopped by addition of 25 mM of guani-
dine and the 
32P incorporation was measured by spotting 25  l of the re-
action mixture onto duplicate phosphocellulose filters (GIBCO BRL). After
air drying for 20 min, the filters were washed five times for 5 min in 75
mM H3PO4 and dried before scintillation counting. Specificity of the PKA
assay was assessed by performing the reaction in the presence of 4 ng
(200 nM) of PKI (PKA-specific inhibitor peptide). Unspecific 
32P incorpora-
tion was measured in the absence of kemptide. PKA assay conditions (pro-
tein amount and reaction time) were adjusted to ensure linear reaction
rates.
Ca
2  measurements and data analysis
Parasite loading with Ca
2  indicators was performed as described in Gar-
cia et al. (1996) and Hotta et al. (2000). RBCs infected P. falciparum
were washed three times at room temperature by centrifugation at 1,500 g
for 5 min in PBS. Isolated parasites were obtained by lysing infected
cells (10
8 cells) with 10 mg/ml
 1 saponin in PBS. After pelleting to remove
red cell membrane material, the parasites were washed twice in PBS by
centrifugation at 2,000 g  at room temperature. Parasites were then
washed twice in buffer A (116 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4,
5.5 mM D-glucose and 50 mM Mops, pH 7.2, 2 mM CaCl2), and resus-
pended in the same buffer containing probenecid, an inhibitor of organic
anion transport (Di Virgilio et al., 1990). A stock solution of Fluo-4 AM in
DMSO (1 mg/ml
 1) was added to the parasite suspension to reach a final
concentration of 5  M and left for 50 min at 37 C. At the end of the incu-
bation, the cells were washed three times with buffer A to remove extracel-
lular dye and placed in the microscopy dishes. The experiments were per-
formed at room temperature. The data acquisition was performed as
described in Gazarini et al. (2003) with a Zeiss confocal microscope
(LSM 510; Microlmaging, Inc.); excitation 488 nm (Argon laser) and
emission collected with band pass filter 505–530 nm. The Axiovert 100M
microscope is equipped with 63  water immersion objective. In the ex-CALCIUM AND CAMP INTERPLAY IN MELATONIN REGULATION ON MALARIA PARASITES • BERALDO ET AL. 557
periments with Fluo-4 AM the fluorescence was normalized (F1   maxi-
mal fluorescence after drug addition/F0   fluorescence before drug addi-
tion). Software-based analysis (LSM 510 software, version 2.5; Carl Zeiss
MicroImaging, Inc.) allowed fluorescence imaging in the whole field of
view (or in a selected cell) as function of time. Experiments were per-
formed with at least three different cell preparations, and 10–20 cells
were monitored in each experiment. Traces represent typical single cell re-
sponses, unless otherwise indicated.
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